CE(22:2(13Z,16Z)) (BioCAD00000020825)

blood feces

Metabolite Card

Formula: C49H84O2 (704.6471)
SMILES: CCCCC\C=C/C\C=C/CCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C

Synonyms [en]

CE(22:2(13Z,16Z)); Cholesteryl docosadienoate; 22:2 Cholesterol ester; Cholesteryl docosadienoic acid; Cholest-5-en-3beta-yl (13Z,16Z-docosadienoate); Cholest-5-en-3beta-yl (13Z,16Z-docosadienoate

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

CE(22:2(13Z,16Z)). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000020825). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Cholesteryl docosadienoic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides).

Extracellular Membrane
Entity Information

DBLinks

Other DBLinks
  • PubChem: 53477893
  • ChEBI: ChEBI:88774
  • HMDB: HMDB0006737
  • HMDB: HMDB06737
  • KEGG: C02530
  • BioCyc: Cholesterol-esters
  • BioCyc: CPD-21817
  • Metlin: METLIN_41712
  • Metlin: METLIN_58536
  • Coconut NaturalProduct: CNP0084748.1

Class / Ontology

Metabolic Network
ID EC Number Name
BioCyc:RXN-20230 2.3.1.26 CPD-21828 + CHOLESTEROL --> CPD-21817 + CO-A
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0120468 Congenital Bile Acid Synthesis Defect Type III
PathBank:SMP0000318 Congenital Bile Acid Synthesis Defect Type III
PathBank:SMP0120697 Familial Hypercholanemia (FHCA)
PathBank:SMP0120463 Cerebrotendinous Xanthomatosis (CTX)
PathBank:SMP0120467 Congenital Bile Acid Synthesis Defect Type II
PathBank:SMP0120495 Zellweger Syndrome
PathBank:SMP0000035 Bile Acid Biosynthesis
PathBank:SMP0000314 Congenital Bile Acid Synthesis Defect Type II
PathBank:SMP0000315 Cerebrotendinous Xanthomatosis (CTX)
PathBank:SMP0087329 Bile Acid Biosynthesis
PathBank:SMP0120652 27-Hydroxylase Deficiency
PathBank:SMP0120688 Congenital Bile Acid Synthesis Defect Type III
PathBank:SMP0120477 Familial Hypercholanemia (FHCA)
PathBank:SMP0000317 Familial Hypercholanemia (FHCA)
PathBank:SMP0087236 Bile Acid Biosynthesis
PathBank:SMP0120683 Cerebrotendinous Xanthomatosis (CTX)
PathBank:SMP0120687 Congenital Bile Acid Synthesis Defect Type II
PathBank:SMP0120715 Zellweger Syndrome
PathBank:SMP0120871 27-Hydroxylase Deficiency
PathBank:SMP0000316 Zellweger Syndrome
View All Pathways